Annovis Bio Appoints Matthew Peterson, Ph.D., as Senior Clinical Scientist - Stock Titan

Summary

The article discusses Annovis Bio appointing Matthew Peterson as Senior Clinical Scientist to oversee clinical trials for neurodegenerative diseases like Alzheimer's and Parkinson's. The key concept, Alzheimer's, relates to the company's focus on developing therapies. Tags such as 'AxoGen' and 'Clinical trial' highlight Peterson's experience and the trial phase.